Which oxygen saturation level should we use for very premature infants? A randomised controlled trial (BOOST -II UK)

对于早产儿,我们应该使用哪种氧饱和度水平?

基本信息

  • 批准号:
    G0400415/1
  • 负责人:
  • 金额:
    $ 308.12万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2006
  • 资助国家:
    英国
  • 起止时间:
    2006 至 无数据
  • 项目状态:
    已结题

项目摘要

In the UK each year over three thousand babies are born more than 12 weeks premature. Two thirds of these very premature babies now survive, but most grow poorly and many have problems breathing. A quarter have at least one major disability at age two, and many have cerebral palsy. Most of these babies require oxygen therapy for several weeks after birth, but we know that giving babies very high levels of oxygen is toxic to the developing eye which may lead to surgery on the eye in order to try and prevent blindness. We do not know whether very preterm babies should only be given enough oxygen to maintain their levels a little above what it is in if they were still in the womb, or whether we should try and keep the their oxygen levels as high as a baby born at the usual time. If oxygen levels are kept low it is likely to prevent eye damage but it may lead to more deaths and may lead to other disabilities in this group of babies. Alternatively if the oxygen levels are kept high it may cause eye damage but prevent early deaths and other later disability. This randomised study will compare the effects of maintaining the babies oxygen level low (functional arterial oxygen saturations at 85?89%) versus high (functional arterial oxygen saturations at 91?95%) in babies born at less than 28 weeks gestation. The primary outcome for the trial is death and major disability at age 2 years. Secondary outcomes include retinal surgery for retinopathy of prematurity as well as duration of oxygen therapy, chronic lung disease, growth and health service utilisation. The trial will recruit 1,200 babies from 20 UK centres over a period of four years.
在英国,每年有超过3000名婴儿早产超过12周。这些早产儿中有三分之二现在存活了下来,但大多数发育不良,许多人有呼吸问题。四分之一的孩子在两岁时至少有一种主要残疾,许多孩子患有脑瘫。大多数这样的婴儿在出生后几周需要氧气治疗,但我们知道,给婴儿高浓度的氧气对发育中的眼睛是有毒的,这可能导致对眼睛进行手术,以防止失明。我们不知道是否应该只给早产儿提供足够的氧气来维持他们在子宫里时的水平,或者我们是否应该试着让他们的氧气水平和正常时间出生的婴儿一样高。如果氧含量保持在较低水平,可能会防止眼睛受损,但可能会导致更多的死亡,并可能导致这组婴儿出现其他残疾。另外,如果氧含量保持在高水平,可能会造成眼睛损伤,但可以防止早期死亡和其他后来的残疾。这项随机研究将比较维持婴儿低氧水平(功能性动脉氧饱和度为85?89%)与高(功能性动脉血氧饱和度为91?95%),发生在妊娠少于28周的婴儿身上。试验的主要结局是2岁时死亡和主要残疾。次要结果包括早产儿视网膜病变的视网膜手术,以及氧气治疗的持续时间,慢性肺病,生长和健康服务的利用。这项试验将在四年的时间里从英国20个中心招募1200名婴儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Brocklehurst其他文献

Factors influencing perinatal outcomes in women with preterm preeclampsia: A secondary analysis of the PHOENIX trial
  • DOI:
    10.1016/j.preghy.2021.10.002
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jessica Fleminger;Kate Duhig;Paul T Seed;Peter Brocklehurst;Marcus Green;Edmund Juszczak;Neil Marlow;Andrew Shennan;Lucy Chappell
  • 通讯作者:
    Lucy Chappell
Saving Lives, Improving Mothers' Care: Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14
拯救生命,改善母亲护理:2012-14 年英国孕产妇死亡监测以及英国和爱尔兰 2009-14 年孕产妇死亡和发病率机密调查为孕产妇护理提供的经验教训
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Knight;M. Nair;D. Tuffnell;Sara Kenyon;Judy Shakespeare;Peter Brocklehurst;Jenny J. Kurinczuk
  • 通讯作者:
    Jenny J. Kurinczuk
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?
多克隆静脉注射免疫球蛋白能否限制早产儿细胞因子介导的脑损伤和慢性肺病?
Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations
  • DOI:
    10.1186/1471-2393-12-7
  • 发表时间:
    2012-02-10
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Marian Knight;Cynthia Berg;Peter Brocklehurst;Michael Kramer;Gwyneth Lewis;Jeremy Oats;Christine L Roberts;Catherine Spong;Elizabeth Sullivan;Jos van Roosmalen;Joost Zwart
  • 通讯作者:
    Joost Zwart
The incidence, characteristics, managements and outcomes of anaphylaxis in pregnancy: a UK population-based descriptive study.
妊娠期过敏反应的发生率、特征、治疗和结果:一项基于英国人群的描述性研究。
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stephen J. McCall;Kathryn J. Bunch;Peter Brocklehurst;Rhiannon D’Arcy;Kim;Hinshaw;Jenny J. Kurinczuk;D. N. Lucas;Benjamin Stenson;D. Tuffnell;Marian Knight
  • 通讯作者:
    Marian Knight

Peter Brocklehurst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Brocklehurst', 18)}}的其他基金

Maternal morbidity after caesarean section in developing countries: long term follow-up of a large factorial trial
发展中国家剖腹产后孕产妇发病率:大型析因试验的长期随访
  • 批准号:
    G1000469/1
  • 财政年份:
    2011
  • 资助金额:
    $ 308.12万
  • 项目类别:
    Research Grant
A randomised, controlled trial of iodide supplementation in preterm infants
早产儿补充碘的随机对照试验
  • 批准号:
    G0800631/1
  • 财政年份:
    2009
  • 资助金额:
    $ 308.12万
  • 项目类别:
    Research Grant
Prevention of maternal morbidity after caesarean section in developing countries: a factorial RCT of surgical methods
发展中国家剖腹产后孕产妇发病率的预防:手术方法的析因随机对照试验
  • 批准号:
    G0500959/1
  • 财政年份:
    2006
  • 资助金额:
    $ 308.12万
  • 项目类别:
    Research Grant

相似国自然基金

高饱和磁感应强度及良好高频特性的新型高性能软磁薄膜的研究
  • 批准号:
    60371016
  • 批准年份:
    2003
  • 资助金额:
    20.0 万元
  • 项目类别:
    面上项目

相似海外基金

Robust, Contrast-Free Functional Renal MRI
稳健、无对比的功能性肾脏 MRI
  • 批准号:
    10578551
  • 财政年份:
    2023
  • 资助金额:
    $ 308.12万
  • 项目类别:
Push-Button Cardiac MRI for Non-Invasive Quantification of Myocardial Energy Consumption in Heart Failure
按钮式心脏 MRI 用于心力衰竭心肌能量消耗的无创定量
  • 批准号:
    10503631
  • 财政年份:
    2022
  • 资助金额:
    $ 308.12万
  • 项目类别:
MRI-Based Regional Assessment of Cerebral Metabolism Via 3D Quantitative BOLD
通过 3D 定量 BOLD 进行基于 MRI 的脑代谢区域评估
  • 批准号:
    10578782
  • 财政年份:
    2022
  • 资助金额:
    $ 308.12万
  • 项目类别:
Push-Button Cardiac MRI for Non-Invasive Quantification of Myocardial Energy Consumption in Heart Failure
按钮式心脏 MRI 用于心力衰竭心肌能量消耗的无创定量
  • 批准号:
    10684051
  • 财政年份:
    2022
  • 资助金额:
    $ 308.12万
  • 项目类别:
MRI-Based Regional Assessment of Cerebral Metabolism Via 3D Quantitative BOLD
通过 3D 定量 BOLD 进行基于 MRI 的脑代谢区域评估
  • 批准号:
    10373235
  • 财政年份:
    2022
  • 资助金额:
    $ 308.12万
  • 项目类别:
High Spatial and Temporal Resolution MRI Mapping of Oxygen Consumption in Humans
人类耗氧量的高时空分辨率 MRI 绘图
  • 批准号:
    10490825
  • 财政年份:
    2021
  • 资助金额:
    $ 308.12万
  • 项目类别:
Multispectral cellular-level retinal imaging for early detection of Alzheimer’s disease
用于早期检测阿尔茨海默病的多光谱细胞水平视网膜成像
  • 批准号:
    10323717
  • 财政年份:
    2021
  • 资助金额:
    $ 308.12万
  • 项目类别:
High Spatial and Temporal Resolution MRI Mapping of Oxygen Consumption in Humans
人类耗氧量的高时空分辨率 MRI 绘图
  • 批准号:
    10172052
  • 财政年份:
    2021
  • 资助金额:
    $ 308.12万
  • 项目类别:
High Spatial and Temporal Resolution MRI Mapping of Oxygen Consumption in Humans
人体耗氧量的高时空分辨率 MRI 绘图
  • 批准号:
    10669230
  • 财政年份:
    2021
  • 资助金额:
    $ 308.12万
  • 项目类别:
Miniature EPR sensor for on-site oximetry
用于现场血氧测定的微型 EPR 传感器
  • 批准号:
    9281723
  • 财政年份:
    2016
  • 资助金额:
    $ 308.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了